Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-23

FDA Approved: AMLODIPINE AND OLMESARTAN MEDOXOMIL — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

The FDA approved a supplemental application for the combination drug amlodipine and olmesartan medoxomil from Ascend Laboratories, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine and olmesartan medoxomil (amlodipine and olmesartan medoxomil)

Snippet

SUPPL AP for AMLODIPINE AND OLMESARTAN MEDOXOMIL (AMLODIPINE AND OLMESARTAN MEDOXOMIL)